Novartis Eye Drug Works With Fewer Injections Than Rivals Novartis Eye Drug Works With Fewer Injections Than Rivals

A drug developed by Novartis to treat vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron to be effective, clinical trials showed on Tuesday.Reuters Health Information
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Source Type: news